IL17A and leprosy: To validate whether enhanced IL-6R expression on CD4+ T cells is causative of elevated IL-17A response in T1R leprosy patients, we studied the effect of blocking of IL-6R and IL-23R in MLSA induced IL-17A production by PBMCs cells in-vitro.